IVHEM
Meeting category
Date(s)
3 Dec 2021 - 4 Dec 2021
Meeting type
Virtual Meeting
EACCME
6
Meeting Organizer
Co-Convener
Sponsor logos
CGHE_TFGH

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

Related Enduring Materials

Enduring Materials
Final Program

All times indicated in the program are in Central European Time (CET)Click here to convert the time into your time zone

Day 1 - Friday, 3 December 2021
Opening Session - 14:00
14:00
Welcome, Introduction, and Goals
Huma Qureshi, MD
Pakistan Medical Research Council, Karachi, Pakistan
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Session 1: Viral Hepatitis Elimination: Where Do We Stand? (HepB and HepC) -
Chairs:
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
14:05
Viral Hepatitis Elimination on a Global Scale
Meg Doherty, MD, PhD
WHO, Switzerland
14:33
Viral Hepatitis Elimination Status in Portugal
Rui Tato Marinho, MD, PhD
University Hospital Center of North Lisbon, Medical School of Lisbon, Directorate-General of Health, Ministry of Health, Portugal
14:42
Viral Hepatitis Elimination Status in Pakistan
Huma Qureshi, MD
Pakistan Medical Research Council, Karachi, Pakistan
14:53
Viral Hepatitis Elimination Status in Brazil - HDV in the Amazonian Basin
Mário Guimarães Pessoa, MD, PhD
Division of Gastroenterology and Hepatology University of São Paulo School of Medicine, Brazil
15:07
Viral Hepatitis Elimination Status in China
Liang Xiaofeng, MD
Jinan University, China
15:17
Viral Hepatitis Elimination Status in Ghana
Atsu Godwin Seake-Kwawu, MB, ChB, MPH, MPSM
National Viral Hepatitis Control Programme, Ghana Health Service, Ghana
15:28
Viral Hepatitis Elimination Status in India
Shiv Kumar Sarin, MD, DM
Institute of Liver and Biliary Sciences, India
15:51
Panel Discussion: Pros-Cons on Integrated Versus Stand-Alone Planning and Programs for Hepatitis Elimination
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
Session 2: Innovative Strategies to Accelerate Progress Towards Elimination -
Chairs:
Marcelo Silva, MD
Latin American Association for the Study of the Liver, Austral University Hospital, Argentina
Huma Qureshi, MD
Pakistan Medical Research Council, Karachi, Pakistan
16:30
Abstract-Driven Presentations
Hepatitis C Elimination in the US Department of Veterans Affairs Healthcare System: 2014 to 2021
#1 Rachel Gonzalez
Community-Based and HIV Integrated Testing for Viral Hepatitis B and C in Vietnam: Preliminary Results From the HepLINK Project
#2 Bao VU
Effectiveness of the Implementation of a Re-Linkage to Care Strategy in Patients with Hepatitis C Who Were Lost of Follow-Up
#3 Manuel Mendizabal
A New Model of Care for Hepatitis B and C Based on a Community Intervention Focused on Migrants From Endemic Countries Living in Catalonia
#4 Elisa Martró
Usability Evaluation and Implementation of a Health Information Technology Dashboard of Evidence-Based Quality Indicators
#5 Karine Rozenberg-Ben-Dror
Chairs:
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Huma Qureshi, MD
Pakistan Medical Research Council, Karachi, Pakistan
17:40
Building Global Capacity for Hepatitis Elimination (World Economic Forum)
Genya V. Dana, PhD
World Economic Forum, Switzerland
18:08
Closing Lecture
Harvey J. Alter, MD, MACP
NIH Clinical Center's Department of Transfusion Medicine, United States
Day 2 - Saturday, 4 December 2021
Welcome & Recap of the First Day - 14:00
14:00
Welcome and Recap of the Previous Day
Session 3: National Hepatitis Elimination Programs & Scale-Up Strategies - Addressing the Gaps -
Chairs:
Jessica Howell, MBBS, FRACP, PhD, MSc, PGDip, PH
University of Melbourne / Burnet Institute, Australia
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease, Canada
14:05
Revised Targets of Incidence and Mortality for Hepatitis Elimination  
Olufunmilayo Lesi, MD, MBA, FWACP, FMCP
World Health Organization, Switzerland
14:22
Global, Regional, and National Burden of Hepatitis B, 1990–2019: from the Global Burden of Disease Study 2019
14:41
The Role of Modeling: Strengths and Limitations
Jag Chhatwal, PhD
Massachusetts General Hospital / Harvard Medical School, United States
14:56
Example Monitoring Implementation; Tracking Progress and Progress Toward New WHO Goals: Egypt
Mohamed Hassany, M.B.BCh., M.Sc., M.D.
National Hepatology and Tropical Medicine Research Institute (NHTMRI), Egypt
15:12
Example Monitoring Implementation; Tracking Progress and Progress Toward New WHO Goals: Spain
Joaquin Cabezas, MD
Marques de Valdecilla University Hospital, Spain
15:25
Liver Cancer in Sub-Saharan Africa
15:43
Abstract Driven Presentations
Progress Towards Hepatitis C (HCV) Elimination in Punjab, India: An Update
#6 Karan Singla
A Pilot Sentinel Surveillance to Monitor the Treatment of Chronic Hepatitis B and C Infections in European Centres in 2019
#7 Lina Nerlander
Session 4: Family Approach to Prevent Viral Hepatitis -
Chairs:
Rosmawati Mohamed, MD, MRCP, MIntMed, MBBS
University Malaya Medical Centre, Malaysia
Michael Ninburg
Hepatitis Education Project (HEP), United States
16:40
Treating Social Networks of PWID for HCV e.g. "Bring Your Mate” in Australia or Others  
16:56
The Evidence for Routine HCV Screening of Pregnant Women
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
17:12
A Whole Family Approach to HBV Prevention
Rangsima Lolekha, MD
U.S. Centers for Disease Control and Prevention (CDC), Thailand Office, Thailand
Surasith Chaithongwongwatthana, MD, MSc
Chulalongkorn University, Thailand
17:23
Catch-Up Vaccination: Hep A and Hep B   
Jorge Enrique Gonzalez, MBiochem
National Administration for Laboratories and Institutes of Health "Dr. Carlos G. Malbrán", National Ministry of Health, Argentina
17:38
Hep C Screening During Pregnancy: Where Do We Stand (US example)
Lakshmi Panagiotakopoulos, MD, MPH
Centers for Disease Control and Prevention (CDC), United States
17:54
Abstract Driven Presentations
Leveraging COVID-19 Vaccination to Enhance HCV Testing in Priority Populations
#8 Aaron Vanderhoff
Overview
Welcome

The International Viral Hepatitis Elimination Meeting (IVHEM) took place as a virtual meeting from 3-4 December 2021. Convened in partnership between Virology Education and the Coalition for Global Hepatitis Elimination (CGHE), IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress towards the elimination of viral hepatitis as a public health threat by 2030.

Hepatitis B and C affect more than 320 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 248 million people (3.8% of the world’s population) are chronically infected with HBV, and over 700,000 attributable deaths annually. An estimated 80 million people (globally, 1.1%) are chronically infected with hepatitis C virus (HCV), resulting in nearly 500,000 deaths annually.

Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two day meeting, experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis and increase the number of people accessing testing and treatment.

The program includes practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment.

We invite you to contribute to the elimination of viral hepatitis and look forward to welcoming you to this unique meeting virtually!

The Organizing Committee

Program Chairs 2021
Ward, John 2023
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
General Information 
COVID-19 Update
Responding to the changing COVID-19 situation, the International Viral Hepatitis Elimination Meeting 2021 (IVHEM) will be held as a virtual meeting. This virtual workshop format is an optimal solution in light of the current circumstances.

We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Christina Dammers via Christina.Dammers@amededu.com
Who Should Attend?
- Healthcare professionals

- Clinicians

- Researchers

- Policymakers

- Virologists

- Pharmacologists

- Industry representatives

- Community representatives
Meeting Objectives
This meeting aims to:

- Provide a forum for knowledge exchange and discussion of practical experiences related to the clinical management of viral hepatitis;

- Provide a toolbox for the practical application of research & development for evidence-based policymaking; and

- Facilitate cross-disciplinary discussion on barriers and challenges preventing the elimination of viral hepatitis.
Learning Objectives
After participating in this activity, participants will be able to:

- Identify innovative strategies for hepatitis b and hepatitis C testing and linkage to care and how these can be applied to their program and clinical activities;

- Recognize the needs from a public health perspective and respond to these needs by reshaping their policymaking approaches;

- Further develop new or strengthen already existing foundations for political commitment, national planning, and program improvements; and

- Translate the latest research and technologies into clinical policy and practice for delivering an adequate continuum of viral hepatitis services.
Practical Information 
Certificate of Attendance
A certificate of attendance will be sent to participants after successfully completing the meeting and post-workshop survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Enduring Materials
Enduring materials will be available here shortly after the conclusion of the meeting.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the meeting is finished, provided that the speaker has given permission to do so.
Partners

A 25% discount on the meeting registration fee is offered to the members/employees of our endorsers. Please reach out to your organization for your discount code.

If you would like your organization to endorse IVHEM 2021, please contact Christina Dammers at christina.dammers@amededu.com 

Media Partner
Committees
Program Chairs 2021
Ward, John 2023
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Organizing Committee
Marcelo Silva
Marcelo Silva, MD
Latin American Association for the Study of the Liver, Austral University Hospital, Argentina

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee
  • Rakesh Aggarwal, MD (AIIMS), DM (PGIMER), FNASc, FAMS - Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India

  • Po-Lin Chan, MD - World Health Organization, Philippines

  • Graham Cooke, MD, PhD - Imperial College London, United Kingdom

  • Gagandeep Singh Grover, MD - Health and Family Welfare, India

  • Saeed Hamid, MBBS, FRCP, FRCPI, FACP, FACG, FAASLD - Aga Khan University, Pakistan

  • Angelos Hatzakis, MD, PhD, MSc - Athens University Medical School, Greece

  • Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD - Burnet Institute, Australia

  • Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP - Myanmar Liver Foundation, Myanmar

  • Jeffrey Lazarus, PhD, MIH, MA - ISGlobal, Spain

  • Maud Lemoine, MD, PhD - Imperial College London, United Kingdom

  • Liudmyla Maistat - Medicines Patent Pool, Switzerland

  • Hailemichael Desalegn Mekonnen, MD, PhD - St. Paul’s Hospital Millennium Medical College, Ethiopia

  • Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana

  • Ponsiano Ocama, MD, PhD - Makerere University, Uganda

  • Jean-Michel Pawlotsky, MD, PhD - Hôpital Henri Mondor, France

  • Homie Razavi, PhD, MBA - Center for Disease Analysis (CDA), United States

  • Shiv. K. Sarin, MD, DM, DSc. (Hony.), FNA, FNAS - Institute of Liver and Biliary Sciences (ILBS), India

  • Janvier Serumondo, MD - Rwanda Biomedical Centre, Rwanda

  • Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland

  • Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed - University of Cape Town, South Africa

  • Nasamon Wanlapakorn, MD, PhD - Chulalongkorn University, Thailand

The members of Scientific Committee are hand-picked by the Organizing Committee and the workshop secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Platinum Level Sponsor

IVHEM 2021 is Convened in partnership between Virology Education and the Coalition for Global Hepatitis Elimination (CGHE). 

Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in the elimination of viral hepatitis.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Karin Siebelt at Karin.Siebelt@amededu.com or call +31 30 230 7149

 

Language